151 related articles for article (PubMed ID: 26076441)
21. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
22. Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.
Ma L; Xu G; Sotnikova A; Szczepanowski M; Giefing M; Krause K; Krams M; Siebert R; Jin J; Klapper W
Br J Haematol; 2007 Oct; 139(2):217-23. PubMed ID: 17897297
[TBL] [Abstract][Full Text] [Related]
23. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
24. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
[TBL] [Abstract][Full Text] [Related]
25. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
26. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotyping without antibodies. New perspectives for lymphoma characterization.
Tinguely M; Hofmann A; Bausch-Fluck D; Moch H; Wollscheid B
Pathologe; 2008 Nov; 29 Suppl 2():314-6. PubMed ID: 18810443
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
Barros MH; Hassan R; Niedobitek G
Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
[TBL] [Abstract][Full Text] [Related]
29. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
30. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.
Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S
Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.
Fromm JR
Cytometry B Clin Cytom; 2011 Mar; 80(2):91-9. PubMed ID: 20809502
[TBL] [Abstract][Full Text] [Related]
32. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
33. Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.
Wu R; Nijland M; Rutgers B; Veenstra R; Langendonk M; van der Meeren LE; Kluin PM; Li G; Diepstra A; Chiu JF; van den Berg A; Visser L
PLoS One; 2016; 11(1):e0146624. PubMed ID: 26752561
[TBL] [Abstract][Full Text] [Related]
34. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
[TBL] [Abstract][Full Text] [Related]
35. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
36. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L
Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500
[TBL] [Abstract][Full Text] [Related]
38. Alterations of the CD58 gene in classical Hodgkin lymphoma.
Schneider M; Schneider S; Zühlke-Jenisch R; Klapper W; Sundström C; Hartmann S; Hansmann ML; Siebert R; Küppers R; Giefing M
Genes Chromosomes Cancer; 2015 Oct; 54(10):638-45. PubMed ID: 26194173
[TBL] [Abstract][Full Text] [Related]
39. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment.
Post GR; Yuan Y; Holthoff ER; Quick CM; Post SR
PLoS One; 2019; 14(11):e0224621. PubMed ID: 31714922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]